FrancophonIA/ELRC3.0 huggingface dataset:
English: Mucosal hyperplasia, with diverticulum/cyst formation was observed in the colon and caecum of mice after 2-years treatment, but this was considered a species-specific effect with no diverticula/cysts seen in long term studies in rats or dogs.
Croatian: Hiperplazija sluznice s formacijom divertikula/cisti primijećena je u debelom i slijepom crijevu miševa nakon dvije godine liječenja, ali se ovo smatralo učinkom specifičnim za vrstu jer divertikuli/ciste nisu primijećeni u dugoročnim ispitivanjima kod štakora i pasa.
English: If you take more Velphoro than you should
Croatian: Ako uzmete više lijeka Velphoro nego što ste trebali
English: Phosphate binding takes place by ligand exchange between hydroxyl groups and/or water and the phosphate ions throughout the physiological pH range of the gastrointestinal tract.
Croatian: Vezanje fosfata odvija se putem izmjene liganda između hidroksilnih skupina i/ili vode i fosfatnih iona u cijelom fiziološkom rasponu pH probavnog sustava.
English: Product taste abnormal
Croatian: Neuobičajen okus lijeka
English: It may also lead to calcium deposits in soft tissues and bone causing effects such as red eyes, itchy skin and bone pain.
Croatian: Može doći i do nakupljanja kalcija u mekim tkivima i kostima, što može prouzročiti crvenilo očiju, svrbež kože i bol u kostima.
English: One phase 3 clinical study has been performed in patients with CKD on dialysis to investigate the efficacy and safety of Velphoro in this population.
Croatian: Provedeno je jedno kliničko ispitivanje faze 3 u bolesnika s KBB­om na dijalizi kako bi se istražila djelotvornost i sigurnost lijeka Velphoro u toj populaciji.
English: The vast majority of these gastrointestinal disorders occurred early during treatment and abated with time with continued dosing.
Croatian: Velika većina ovih poremećaja probavnog sustava pojavila se rano tijekom liječenja i povukla se s vremenom i nastavkom liječenja.
English: Velphoro is a chewable tablet that must be taken with meals.
Croatian: Velphoro je tableta za žvakanje koja se mora uzimati uz obroke.
English: They have been conducted in healthy human male and female subjects with losartan, furosemide, digoxin, warfarin, and omeprazole.
Croatian: Ova ispitivanja provedena su na zdravim ljudskim muškim i ženskim ispitanicima s losartanom, furosemidom, digoksinom, varfarinom i omeprazolom.
English: What you need to know before you take Velphoro
Croatian: Što morate znati prije nego počnete uzimati Velphoro
English: In healthy subjects, the median uptake of radiolabelled iron in the blood was estimated to be 0.43% (range 0.16 - 1.25%) on Day 21, in pre-dialysis patients 0.06% (range 0.008 - 0.44%) and in haemodialysis patients 0.02% (range 0 - 0.04%).
Croatian: U zdravih ispitanika, medijan apsorpcije radioaktivno označenoga željeza u krvi procijenjen je na 0,43% (raspon 0,16-1,25%) na 21. dan, u bolesnika u predijalizi 0,06% (raspon 0,008-0,44%), a u bolesnika na hemodijalizi 0,02% (raspon 0-0,04%).
English: Velphoro works by binding phosphate in the gastrointestinal tract and thus the serum concentration is not relevant for its efficacy.
Croatian: Velphoro djeluje vezanjem fosfata u probavnom sustavu pa zato koncentracija u serumu nije relevantna za njegovu djelotvornost.
English: Velphoro should only be used in these patients following careful assessment of benefit/risk.
Croatian: U takvih bolesnika Velphoro treba primjenjivati samo nakon pažljive procjene koristi/rizika.
English: Non-clinical studies in several species (rats and dogs) showed that pn-FeOOH is distributed from the plasma to the liver, spleen and bone marrow, and utilized by incorporation into red blood cells.
Croatian: Neklinička ispitivanja provedena na nekoliko vrsta (štakorima i psima) pokazala su da se pn­FeOOH distribuira iz plazme u jetru, slezenu i koštanu srž te da se iskoristi ugradnjom u eritrocite.
English: Description of selected adverse reactions *Diarrhoea
Croatian: Opis odabranih nuspojava *Proljev
English: Do not use this medicine after the expiry date stated on the carton, bottle or blister after “EXP”.
Croatian: Ovaj lijek se ne smije se upotrijebiti nakon isteka roka valjanosti navedenog na kutiji, boci ili blisteru iza oznake „Rok valjanosti”.
English: Data from clinical studies have shown that Velphoro does not affect the lipid lowering effects of HMG-CoA reductase inhibitors (e.g., atorvastatin and simvastatin).
Croatian: Podaci iz kliničkih ispitivanja pokazali su da Velphoro ne utječe na učinke snižavanja razine lipida inhibitora HMG­CoA (npr. atorvastatin i simvastatin).
English: If you have black stools and also have symptoms like increasing tiredness and breathlessness contact your doctor immediately (see section 4).
Croatian: Ako imate crnu stolicu i simptome poput povećanog umora ili nedostatka zraka, odmah se obratite svome liječniku (pogledajte dio 4).
English: Child-resistant aluminium/aluminium perforated unit-dose blister, each blister containing 6 chewable tablets.
Croatian: Aluminij/aluminijski perforirani blister s jediničnim dozama siguran za djecu, svaki blister sadrži 6 tableta za žvakanje.
English: Velphoro should be used within the context of a multiple therapeutic approach, which could include calcium supplement, 1,25-dihydroxy vitamin D3 or one of its analogues, or calcimimetics to control the development of renal bone disease.
Croatian: Velphoro treba primjenjivati u sklopu višestrukog terapijskog pristupa, koji može obuhvaćati nadomjestak kalcija, 1,25­dihidroksi vitamin D3 ili neki od njegovih analoga, ili kalcimimetike za kontrolu razvoja bubrežne osteodistrofije.
English: Method of administration - Velphoro should only be taken by mouth.
Croatian: Način primjene lijeka - Velphoro se smije uzimati samo kroz usta.
English: Uncommon (may affect up to 1 in 100 people): bloating (abdominal distension), inflammation of the stomach, abdominal discomfort, difficulty swallowing, acid coming back up from the stomach (gastrooesophageal reflux disease), tongue discolouration, low or high calcium levels in the blood seen in tests, tiredness, itch, rash, headache, shortness of breath.
Croatian: Manje često (mogu se javiti u do 1 na 100 osoba): nadutost (nadimanje trbuha), upala želuca, nelagoda u trbuhu, otežano gutanje, vraćanje kiseline iz želuca (gastroezofagealna refluksna bolest), promjena boje jezika, niska ili visoka razina kalcija uočena u krvnim pretragama, umor, svrbež, osip, glavobolja, nedostatak zraka.
English: Patients with severe hepatic impairment were excluded from participating in clinical studies with Velphoro.
Croatian: Bolesnici s teškim oštećenjem funkcije jetre bili su isključeni iz sudjelovanja u kliničkim ispitivanjima s lijekom Velphoro.
English: In vitro data suggest that the sucrose and starch components of the drug substance can be digested to glucose and fructose, and maltose and glucose, respectively.
Croatian: In vitro podaci ukazuju da se dijelovi lijeka, saharoza i škrob, mogu razgraditi u glukozu i fruktozu, odnosno maltozu i glukozu.
English: The active moiety of Velphoro, pn-FeOOH, is not metabolised.
Croatian: Aktivni dio lijeka Velphoro, pn­FeOOH, se ne metabolizira.
English: In patients, absorbed iron is expected to be also distributed to the target organs, i.e. liver, spleen and bone marrow, and utilized by incorporation into red blood cells.
Croatian: Očekuje se da se apsorbirano željezo kod bolesnika također distribuira u ciljne organe, tj. jetru, slezenu i koštanu srž te da se iskoristi ugradnjom u eritrocite.
English: In clinical practice, treatment will be based on the need to control serum phosphorus levels, though patients who respond to Velphoro therapy usually achieve optimal serum phosphorus levels at doses of 1,500 - 2,000 mg iron per day (3 to 4 tablets).
Croatian: U kliničkoj praksi liječenje će se temeljiti na potrebi za kontrolom razine fosfora u serumu, premda bolesnici koji reagiraju na terapiju lijekom Velphoro obično postižu optimalne razine fosfora u serumu pri dozama od 1500 - 2000 mg željeza na dan (3 do 4 tablete).
English: 90 chewable tablets
Croatian: 90 tableta za žvakanje
English: There are no data on the effect of Velphoro on fertility in humans.
Croatian: Nema podataka o učinku lijeka Velphoro na plodnost u ljudi.
English: Common (may affect up to 1 in 10 people): feeling sick (nausea), constipation, vomiting, indigestion, pain in stomach and gut, gas, tooth discolouration, change in taste.
Croatian: Često (mogu se javiti u do 1 na 10 osoba): mučnina, zatvor, povraćanje, probavne smetnje, bolovi u želucu i crijevima, plinovi, promjena boje zuba, promjena osjeta okusa.
English: The response rates, defined as the proportion of subjects achieving serum phosphorus levels within the KDOQI (Kidney Disease Outcomes Quality Initiative) recommended range were 45.3% and 59.1% at week 12 and 51.9% and 55.2% at week 52, for Velphoro and sevelamer carbonate, respectively.
Croatian: Stope odgovora, definirane kao udio ispitanika koji su postigli razine fosfora u serumu unutar preporučenog raspona prema KDOQI (Kidney Disease Outcomes Quality Initiative, Inicijativa za kvalitetu ishoda bubrežnih bolesti), bile su 45,3% u 12.tjednu i 51,9% u 52. tjednu za Velphoro, a 59,1% i 55,2% u istim tjednima za sevelamerkarbonat.
English: Concomitant administration of Velphoro did not affect the bioavailability of these medicinal products as measured by the area under the curve (AUC).
Croatian: Istodobna primjena lijeka Velphoro nije utjecala na bioraspoloživost tih lijekova, mjereno površinom ispod krivulje (AUC).
English: (rats and dogs) showed that systemic absorption was very low (≤1% of the administered dose).
Croatian: Neklinička ispitivanja provedena na nekoliko vrsta (štakorima i psima) pokazala su da je sistemska apsorpcija bila vrlo niska (≤ 1% primijenjene doze).
English: If you are not sure if any of the above applies to you, talk to your doctor or pharmacist before taking this medicine.
Croatian: Ako niste sigurni odnosi li se išta od gore navedenog na vas, obratite se svom liječniku ili ljekarniku prije nego uzmete ovaj lijek.
English: In animal studies, there were no adverse effects on mating performance, fertility, and litter parameters following treatment with Velphoro (see section 5.3).
Croatian: U ispitivanjima provedenim na životinjama nije bilo nikakvih štetnih učinaka na sposobnost parenja, plodnost i parametre legla nakon liječenja lijekom Velphoro (vidjeti dio 5.3).
English: The maximum recommended dose is 3,000 mg iron (6 tablets) per day.
Croatian: Maksimalna preporučena doza je 3000 mg željeza (6 tableta) na dan.
English: Although the potential for interactions with medicinal products seems low, for concomitant treatment with medicinal products with a narrow therapeutic window, the clinical effect and adverse events should be monitored, on initiation or doseadjustment of either Velphoro or the concomitant medicinal product, or the physician should consider measuring blood levels.
Croatian: Iako je potencijal za interakcije s drugim lijekovima nizak, pri istodobnom liječenju lijekovima s uskom terapijskom širinom, na početku liječenja ili kod prilagodbe doze lijeka Velphoro ili istodobno primijenjenog lijeka, potrebno je pratiti klinički učinak i nuspojave ili liječnik treba razmotriti mjerenje razina u krvi.
English: A decision on whether to continue breast-feeding or to continue therapy with Velphoro should be made taking into account the benefit of breast-feeding to the child and the benefit of Velphoro therapy to the mother.
Croatian: Odluku o tome hoće li se nastaviti s dojenjem ili s terapijom lijekom Velphoro treba donijeti uzimajući u obzir korist od dojenja za dijete i korist od terapije lijekom Velphoro za majku.
English: Velphoro is for use by adult patients who undergo haemodialysis or peritoneal dialysis (procedures to eliminate toxic substances from the blood) because of chronic kidney disease; it is used in order to help control the phosphorus level in their blood when it is too high (hyperphosphataemia).
Croatian: Velphoro je namijenjen za upotrebu odraslim bolesnicima koji su na hemodijalizi ili peritonealnoj dijalizi (postupci za eliminaciju toksičnih tvari iz krvi) zbog kronične bolesti bubrega, a upotrebljava se radi kontroliranja razine fosfora u krvi kada je ona previsoka (hiperfosfatemija).
English: In these clinical trials, approximately 43% of patients experienced at least one adverse reaction during Velphoro treatment, which were reported as serious adverse reactions in 0.36%.
Croatian: U kliničkim ispitivanjima, za vrijeme liječenja lijekom Velphoro u približno 43% bolesnika pojavila se najmanje jedna nuspojava, koja je u 0,36% slučajeva prijavljena kao ozbiljna nuspojava.
English: If you are breastfeeding, your doctor will discuss with you whether to continue breastfeeding or to continue therapy with Velphoro, taking into account the benefit of Velphoro therapy to you and the benefit of breastfeeding to your child.
Croatian: Ako dojite, Vaš će liječnik razgovarati s Vama o tome trebate li nastaviti dojiti ili nastaviti terapiju lijekom Velphoro, uzimajući u obzir korist terapije lijekom Velphoro i korist dojenja za Vaše dijete.
English: INFORMATION IN BRAILLE velphoro
Croatian: 16. PODACI NA BRAILLEOVOM PISMU velphoro
English: If you are taking any other medicine that is known to be affected by iron (for example medicines containing the active substance alendronate (used to treat certain bone disorders) or doxycycline (an antibiotic)) or has the potential to be affected by iron (for example medicines containing the active substance levothyroxine (used to treat thyroid function disorder)), make sure that you take this medicine at least one hour before taking Velphoro or at least two hours after taking Velphoro.
Croatian: Ako uzimate bilo koji drugi lijek za koji je poznato da na njega utječe željezo (kao što su lijekovi koji sadrže djelatnu tvar alendronat (koristi se za liječenje određenih bolesti kostiju) ili doksiciklin (antibiotik)) ili postoji mogućnost da na njega utječe željezo (na primjer lijekovi koji sadrže djelatnu tvar levotiroksin (koristi se za liječenje poremećaja funkcije štitne žljezde)), svakako uzmite taj lijek najmanje jedan sat prije ili dva sata poslije uzimanja lijeka Velphoro.
English: The mean daily dose of Velphoro over 55 weeks of treatment was 1,650 mg iron and the mean daily dose of sevelamer carbonate was 6,960 mg.
Croatian: Srednja dnevna doza lijeka Velphoro tijekom 55 tjedana liječenja iznosila je 1650 mg željeza, a srednja dnevna doza sevelamerkarbonata iznosila je 6960 mg.
English: In addition, post-hoc analyses from clinical studies demonstrated no impact of Velphoro on iPTH lowering effect of oral Vitamin D analogues.
Croatian: Osim toga, post-hoc analize iz kliničkih ispitivanja pokazale su da Velphoro ne utječe na učinak oralnih analoga vitamina
English: The active ingredient sucroferric oxyhydroxide contains 750 mg sucrose and 700 mg starches (potato starch and pregelatinised maize starch) per tablet.
Croatian: Djelatni sastojak saharoželjezov(III) oksihidroksid sadrži 750 mg saharoze i 700 mg škrobova (krumpirov škrob i prethodno gelirani kukuruzni škrob) po tableti.
English: Velphoro can cause black stools.
Croatian: Velphoro može uzrokovati crnu stolicu.
English: The iron uptake from radiolabelled Velphoro drug substance, 2,000 mg iron in 1 day was investigated in 16 CKD patients (8 pre-dialysis and 8 haemodialysis patients) and 8 healthy volunteers with low iron stores (serum ferritin <100 mcg/L).
Croatian: Apsorpcija željeza iz radioaktivno označene djelatne tvari lijeka Velphoro, 2000 mg željeza u 1 danu, istražena je u 16 bolesnika s KBB­om (8 bolesnika u predijalizi i 8 na hemodijalizi) i 8 zdravih dobrovoljaca s niskim zalihama željeza (serumski feritin < 100 µg/l).
English: NAME OF THE MEDICINAL PRODUCT Velphoro 500 mg chewable tablets
Croatian: NAZIV LIJEKA Velphoro 500 mg tablete za žvakanje
English: Treatment of patient sub-populations from week 24 to week 27 with maintenance dose of Velphoro (1,000 to 3,000 mg iron/day) or low dose (250 mg iron/day) of Velphoro demonstrated superiority of the maintenance dose.
Croatian: Liječenje podskupina bolesnika od 24. tjedna do 27. tjedna dozom održavanja lijeka Velphoro (1000 do 3000 mg željeza/dan) ili niskom dozom (250 mg željeza/dan) lijeka Velphoro pokazala je superiornost doze održavanja.
English: Velphoro should only be used by pregnant women if clearly needed following careful assessment of benefit/risk.
Croatian: Trudnice smiju koristiti Velphoro samo ako je to neophodno, nakon pažljive procjene koristi/rizika.
English: If you have diabetes you should take notice that one tablet of Velphoro is equivalent to approximately 1.4 g of carbohydrates (equivalent to 0.116 bread units).
Croatian: Ako imate šećernu bolest trebate imati na umu da jedna tableta lijeka Velphoro sadrži približno 1,4 g ugljikohidrata (što odgovara 0,116 zamjenskih jedinica kruha).
English: The active moiety of Velphoro, pn-FeOOH, is practically insoluble and therefore not absorbed.
Croatian: Aktivni dio lijeka Velphoro, pn­FeOOH, praktički je netopljiv i zato se ne apsorbira.
English: Velphoro contains starches.
Croatian: Velphoro sadrži škrobove.
English: If you stop taking Velphoro
Croatian: Ako prestanete uzimati Velphoro
English: Pack sizes of 30 or 90 chewable tablets.
Croatian: Pakiranja od 30 ili 90 tableta za žvakanje.
English: The chewable tablets are brown, circular, and embossed with PA500 on one side.
Croatian: Tablete za žvakanje su smeđe, okrugle,tablete s utisnutim znakom PA500 na jednoj strani.
English: Discoloured (black) stool may visually mask gastrointestinal bleeding (see section 4.5).
Croatian: Promijenjena (crna) boja stolice može vizualno prikriti krvarenje u probavnom sustavu (vidjeti dio 4.5).
English: Brown, circular tablets embossed with PA500 on one side.
Croatian: Smeđe, okrugle, tablete s utisnutim znakom PA500 na jednoj strani.
English: The majority of the adverse reactions reported from trials were gastrointestinal disorders, with the most frequently reported adverse reactions being diarrhoea and discoloured faeces (very common).
Croatian: Većina nuspojava na lijek prijavljenih tijekom ispitivanja bile su poremećaji probavnog sustava, a najčešće prijavljene nuspojave na lijek bile su proljev i promijenjena boja stolice (vrlo često).
English: Its degradation product, mononuclear iron species, can however be released from the surface of pnFeOOH and be absorbed.
Croatian: Međutim, njegov razgradni produkt, mononuklearni željezovi spojevi, može se otpuštati s površine pn­FeOOH­a i zatim apsorbirati.
English: Tablets have a 20 mm diameter and a thickness of 6.5 mm.
Croatian: Tablete imaju promjer od 20 mm i debljinu 6,5 mm.
English: When administering any medicinal product that is already known to interact with iron (like alendronate and doxycycline) or has the potential to interact with Velphoro based only on in vitro studies like levothyroxine, the medicinal product should be administered at least one hour before or two hours after Velphoro.
Croatian: Kod primjene bilo kojeg lijeka za koji je poznato da stupa u interakciju sa željezom (kao što su alendronat i doksiciklin) ili ima potencijal za interakciju s lijekom Velphoro samo na temelju in vitro ispitivanja, kao što je levotiroksin, lijek treba primijeniti najmanje jedan sat prije ili dva sata nakon primjene lijeka Velphoro.
English: Abdominal distension Gastritis Abdominal discomfort Dysphagia Gastro-oesophageal reflux disease (GORD) Tongue discolouration
Croatian: Distenzija abdomena Gastritis Nelagoda u abdomenu Disfagija Gastroezofagealna refluksna bolest (GERB) Promjena boje jezika
English: MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS BLISTER OF 6 CHEWABLE TABLETS
Croatian: PODACI KOJE MORA NAJMANJE SADRŽAVATI BLISTER ILI STRIP BLISTER OD 6 TABLETA ZA ŽVAKANJE
English: However, the degradation product of Velphoro, mononuclear iron species, can be released from the surface of polynuclear iron(III)oxyhydroxide and be absorbed.
Croatian: Međutim, razgradni produkt lijeka Velphoro, mononuklearni željezovi spojevi, može se oslobađati s površine polinuklearnog željezovog(III) oksihidroksida i apsorbirati se.
English: Information about sucrose and starches (carbohydrates) Velphoro contains sucrose.
Croatian: Informacije o saharozi i škrobovima (ugljikohidrati) Velphoro sadrži saharozu.
English: Velphoro is almost not absorbed from the gastrointestinal tract.
Croatian: Velphoro se gotovo ne apsorbira iz probavnog sustava.
English: Velphoro can cause discoloured (black) stool.
Croatian: Velphoro može uzrokovati promijenjenu (crnu) boju stolice.
English: Following completion of Study-05A, 658 patients (597 on hemodialysis and 61 on peritoneal dialysis) were treated in the 28-week extension study (Study-05B) with either Velphoro (N=391) or sevelamer carbonate (N=267) according to their original randomization.
Croatian: Nakon završetka ispitivanja­05A, 658 bolesnika (597 na hemodijalizi i 61 na peritonealnoj dijalizi) liječeno je u produžetku ispitivanja od 28 tjedana (Ispitivanje­05B) lijekom Velphoro (n=391) ili sevelamerkarbonatom (n=267) prema prvotnoj randomizaciji.
English: Corresponding levels for sevelamer carbonate at baseline were 2.4 mmol/L and 1.7 mmol/L at week 12 (reduction by 0.7 mmol/L), respectively.
Croatian: Odgovarajuće razine za sevelamerkarbonat na početku ispitivanja iznosile su 2,4 mmol/l odnosno 1,7 mmol/l u 12. tjednu (smanjenje za 0,7 mmol/l).
English: If you forget to take Velphoro
Croatian: Ako ste zaboravili uzeti Velphoro
English: There is no clinical data available with Velphoro in patients with earlier stages of renal impairment.
Croatian: Nema dostupnih kliničkih podataka za primjenu lijeka Velphoro u bolesnika s ranijim stadijima oštećenja funkcije bubrega.
English: Patients with diabetes should take notice that one tablet of Velphoro is equivalent to approximately 1.4 g of carbohydrates (equivalent to 0.116 bread units).
Croatian: Bolesnici s dijabetesom trebaju imati na umu da jedna tableta lijeka Velphoro sadrži približno 1,4 g ugljikohidrata (odgovara 0,116 zamjenskih jedinica kruha).
English: Velphoro contains potato starch and pregelatinised maize starch.
Croatian: Velphoro sadrži krumpirov škrob i prethodno gelirani kukuruzni škrob.
English: Adverse reactions reported from the use of Velphoro at doses from 250 mg iron/day to 3,000 mg iron/day in these patients (n=835) are listed in Table 1.
Croatian: Nuspojave na lijek prijavljene pri primjeni lijeka Velphoro u dozama od 250 mg željeza/dan do 3000 mg željeza/dan u tih bolesnika (n=835) prikazane su u Tablici 1.
English: How to take Velphoro
Croatian: Kako uzimati Velphoro
English: Serum phosphorus levels must be monitored and the dose of Velphoro up or down titrated in increments of 500 mg iron (1 tablet) per day every 2 - 4 weeks until an acceptable serum phosphorus level is reached, with regular monitoring afterwards.
Croatian: Razine fosfora u serumu moraju se pratiti, a dozu lijeka Velphoro treba titrirati naviše ili naniže u koracima od 500 mg željeza (1 tableta) na dan, svaka 2 - 4 tjedna, dok se ne postigne zadovoljavajuća razina fosfora u serumu, uz redovito praćenje nakon toga.
English: Velphoro works by binding phosphorus from food in your digestive tract (stomach and intestines).
Croatian: Velphoro veže fosfor iz hrane u vašem probavnom sustavu (želucu i crijevima).
English: - The other ingredients are woodberry flavour, neohesperidin-dihydrochalcone, magnesium stearate, colloidal anhydrous silica.
Croatian: - Drugi sastojci su aroma šumskih bobica, neohesperidindihidrohalkon, magnezijev stearat,
English: This reduces the amount of phosphorus that can be absorbed into the bloodstream and thus lowers phosphorus levels in your blood.
Croatian: Time se smanjuje količina fosfora koja se može apsorbirati u krvotok te njegova razina u krvi.
English: Multipacks are available for the blister packs with 90 chewable tablets (containing 3 individual packs of 30 × 1 chewable tablets each).
Croatian: Višestruka pakiranja dostupna su za blister pakiranja s 90 tableta za žvakanje (sadrže 3 pojedinačna pakiranja sa po 30 × 1 tabletom za žvakanje).